Prevalence, Clinical Features, Treatment, and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries

Aim. To study clinical and demographic characteristics, treatment options, and clinical outcomes in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) compared with patients with myocardial infarction with obstructive coronary arteries (MIOCA).
Material and methods. This single-center prospective observational study included 712 successive patients diagnosed with acute myocardial infarction (MI), who routinely underwent direct coronary angiography. Based on the presence of stenosing coronary atherosclerosis, the patients were divided into two groups: MIOCA (coronary stenosis ≥50%) and MINOCA (coronary stenosis <50% without other, alternative causes). Clinical outcomes included in-hospital and long-term overall mortality, and cardiovascular rehospitalization. The median follow-up was 1.5 years.
Results. MINOCA was diagnosed in 73 (10.3%) patients, 37 (50%) of whom were women. The median age of patients with MINOCA was 61 years and in the MIOCA group 65 years. No significant differences in cardiovascular risk factors were found between patients with MINOCA and MIOCA. In 53.4% of cases, the cause of MINOCA was a discrepancy between the myocardial oxygen demand and supply, and in 35.6% of cases, the cause was hypertensive crisis and pulmonary edema. The factors associated with MINOCA included an age ≤58 years, female gender, absence of the ST-segment elevation, absence of areas of impaired local contractility, and presence of aortic stenosis and bronchopulmonary infection. Patients with MINOCA were less likely to be prescribed acetylsalicylic acid, P2Y12 inhibitors, dual antiplatelet therapy, beta-blockers, and statins (p<0.05). Data on long-term outcomes were available for 87.5% of patients (n=623). The prognosis of patients with MIOCA was comparable for in-hospital mortality (1.5% vs. 6.2%; p=0.161) and long-term overall mortality (6.1% vs. 14.7%; p=0.059). Cardiovascular rehospitalizations were more frequent in the MINOCA group (33.3% vs. 21.5%; p=0.042).
Conclusion. The prevalence of MINOCA in our study was 10.3% among all patients with acute MI. MINOCA patients had comparable generally recognized cardiovascular risk factors with MIOCA patients. MINOCA patients had a comparable prognosis for in-hospital and long-term mortality and more often required cardiovascular rehospitalization.

1. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio ALP et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. European Heart Journal. 2016;38(3):143–53. DOI: 10.1093/eurheartj/ehw149

2. Tavella R, Pasupathy S, Beltrame JF. MINOCA – A personalised medicine approach. International Journal of Cardiology. 2018;267:54–5. DOI: 10.1016/j.ijcard.2018.05.077

3. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393

4. Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries. Circulation. 2015;131(10):861–70. DOI: 10.1161/CIRCULATIONAHA.114.011201

5. Raparelli V, Elharram M, Shimony A, Eisenberg MJ, Cheema AN, Pilote L. Myocardial Infarction With No Obstructive Coronary Artery Disease: Angiographic and Clinical Insights in Patients With Premature Presentation. Canadian Journal of Cardiology. 2018;34(4):468–76. DOI: 10.1016/j.cjca.2018.01.004

6. Barr PR, Harrison W, Smyth D, Flynn C, Lee M, Kerr AJ. Myocardial Infarction Without Obstructive Coronary Artery Disease is Not a Benign Condition (ANZACS-QI 10). Heart, Lung and Circulation. 2018;27(2):165–74. DOI: 10.1016/j.hlc.2017.02.023

7. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third Universal Definition of Myocardial Infarction. Circulation. 2012;126(16):2020–35. DOI: 10.1161/CIR.0b013e31826e1058

8. Arutyunov G.P., Paleev F.N., Moiseeva O.M., Dragunov D.O., Sokolova A.V., Arutyunov A.G. et al. 2020 Clinical practice guidelines for Myocarditis in adults. Russian Journal of Cardiology. 2021;26(11):136–82. DOI: 10.15829/1560-4071-2021-4790

9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40(5):373–83. DOI: 10.1016/0021-9681(87)90171-8

10. Singh M, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL. Scores for Post–Myocardial Infarction Risk Stratification in the Community. Circulation. 2002;106(18):2309–14. DOI: 10.1161/01.CIR.0000036598.12888.DE

11. O’Connell RL, Lim LL. Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes. Methods of Information in Medicine. 2000;39(1):7–11. PMID: 10786063

12. Jacobs DR, Kroenke C, Crow R, Deshpande M, Gu DF, Gatewood L et al. PREDICT: A Simple Risk Score for Clinical Severity and LongTerm Prognosis After Hospitalization for Acute Myocardial Infarction or Unstable Angina: The Minnesota Heart Survey. Circulation. 1999;100(6):599–607. DOI: 10.1161/01.CIR.100.6.599

13. Fox KAA, FitzGerald G, Puymirat E, Huang W, Carruthers K, Simon T et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4(2):e004425. DOI: 10.1136/bmjopen-2013-004425

14. Landes U, Bental T, Orvin K, Vaknin-Assa H, Rechavia E, Iakobishvili Z et al. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction. Journal of Cardiology. 2016;67(1):51–6. DOI: 10.1016/j.jjcc.2015.04.001

15. Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. The American Journal of Medicine. 2013;126(9):789–97. DOI: 10.1016/j.amjmed.2013.02.029

16. Cediel G, Gonzalez-del-Hoyo M, Carrasquer A, Sanchez R, Boqué C, Bardají A. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart. 2017;103(8):616–22. DOI: 10.1136/heartjnl-2016-310243

17. Safdar B, Spatz ES, Dreyer RP, Beltrame JF, Lichtman JH, Spertus JA et al. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study. Journal of the American Heart Association. 2018;7(13):e009174. DOI: 10.1161/JAHA.118.009174

18. Hoang H.T., Kitbalyan A.A., Lazarev P.V., Maiskov V.V., Shkolinikova E.E., Meray I.A. Type 2 myocardial infarction: clinical and demographic features, laboratory and instrumental associations. RUDN Journal of Medicine. 2018;22(2):148–58. DOI: 10.22363/2313-0245-2018-22-2-148-158

19. Kruchinova S.V., Kosmacheva E.D., Porkhanov V.A. Comparative analysis of demographic, anamnestic, clinical-laboratory and instrumental data in patients with myocardial infarction with and without obstructive lesion of coronary arteries. Siberian Medical Journal (Tomsk). 2018;33(4):69–75. DOI: 10.29001/2073-8552-2018-33-4-69-75

20. Kosmacheva E.D., Kruchinova S.V., Raff S.A., Porkhanov V.A. Myocardial infarction with no obstructive coronary atherosclerosis: data from total register of acute coronary syndrome for the Krasnodar territory. Emergency Cardiology. 2016;4:3–10.

21. Ryabov V.V., Syrkina A.G., Belokopytova N.V., Markov V.A., Erlikh A.D. ST elevation acute coronary syndrome in non-obstructive lesion of coronary st elevation acute coronary syndrome in nonobstructive lesion of coronary arteries: data from the registry RECORD-3. Russian Journal of Cardiology. 2017;22(11):15–21. DOI: 10.15829/1560-4071-2017-11-15-21

22. Yakushin S.S. Myocardial Infarction with Nonobstructive Coronary Arteries (МINОСА) – a Trendy Term or a New Diagnostic Concept? Rational Pharmacotherapy in Cardiology. 2018;14(5):765–73. DOI: 10.20996/1819-6446-2018-145-765-773

23. Collste O, Sörensson P, Frick M, Agewall S, Daniel M, Henareh L et al. Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study. Journal of Internal Medicine. 2013;273(2):189–96. DOI: 10.1111/j.1365-2796.2012.02567.x

24. Lanza GA, Careri G, Stazi A, Villano A, De Vita A, Aurigemma C et al. Clinical Spectrum and Outcome of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and No Obstructive Coronary Athe rosclerosis. Circulation Journal. 2016;80(7):1600–6. DOI: 10.1253/circj.CJ-16-0145

25. Dastidar AG, Baritussio A, De Garate E, Drobni Z, Biglino G, Singhal P et al. Prognostic Role of CMR and Conventional Risk Factors in Myocardial Infarction With Nonobstructed Coronary Arteries. JACC: Cardiovascular Imaging. 2019;12(10):1973–82. DOI: 10.1016/j.jcmg.2018.12.023

26. Johnston N, Jönelid B, Christersson C, Kero T, Renlund H, Schenck-Gustafsson K et al. Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease. The American Journal of Cardiology. 2015;115(12):1661–6. DOI: 10.1016/j.amjcard.2015.03.006

27. Abdu FA, Liu L, Mohammed A-Q, Luo Y, Xu S, Auckle R et al. Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: Clinical features, treatment and 1 year follow-up. International Journal of Cardiology. 2019;287:27–31. DOI: 10.1016/j.ijcard.2019.02.036

28. Hoang T.H., Lazarev P.V., Maiskov V.V., Meray I.A., Kobalava Zh.D. Myocardial Infarction with Non-Obstructive Coronary Arteries: Contemporary Diagnostic and Management Approaches. Rational Pharmacotherapy in Cardiology. 2020;15(6):881–91. DOI: 10.20996/1819-6446-2019-15-6-881-891

29. Hoang TH, Lazarev PV, Maiskov VV, Merai IA, Kobalava ZD. Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(5):463–72. DOI: 10.1177/10742484211005929

30. Kilic S, Aydin G, Coner A, Dogan Y, Ozluk OA, Celik Y et al. Prevalence and Clinical Profile of Patients with Myocardial Infarction with Non-obstructive Coronary Arteries in Turkey (MINOCA-TR): A national multi-centre, observational study. The Anatolian Journal of Cardiology. 2020;23(3):176–82. DOI: 10.14744/AnatolJCardiol.2019.46805

31. Blum A, Azani L, Blum N. Community Acquired Pneumonia (CAP), Type 2 Myocardial Infarction (Type 2 MI), and 5 Years Mortality after Discharge. Archives of Medicine. 2017;9(2):4–8. DOI: 10.21767/1989-5216.1000205

32. El-Haddad H, Robinson E, Swett K, Wells GL. Prognostic implications of type 2 myocardial infarctions. World Journal of Cardiovascular Diseases. 2012;2(4):237–41. DOI: 10.4236/wjcd.2012.24039

33. Putot A, Chague F, Manckoundia P, Cottin Y, Zeller M. Post-Infectious Myocardial Infarction: New Insights for Improved Screening. Journal of Clinical Medicine. 2019;8(6):827. DOI: 10.3390/jcm8060827

34. Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. The American Journal of Cardiology. 2009;104(1):9–13. DOI: 10.1016/j.amjcard.2009.03.003

35. Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD et al. Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I. The American Journal of Medicine. 2017;130(12):1431-1439.e4. DOI: 10.1016/j.amjmed.2017.05.049

36. Putot A, Jeanmichel M, Chague F, Manckoundia P, Cottin Y, Zeller M. Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis. Aging and disease. 2020;11(1):108–17. DOI: 10.14336/AD.2019.0405

37. Gard A, Lindahl B, Batra G, Hjort M, Szummer K, Baron T. Diagnosing type 2 myocardial infarction in clinical routine. A validation study. Scandinavian Cardiovascular Journal. 2019;53(5):259–65. DOI: 10.1080/14017431.2019.1638961

38. Smilowitz NR, Weiss MC, Mauricio R, Mahajan AM, Dugan KE, Devanabanda A et al. Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. International Journal of Cardiology. 2016;218:196–201. DOI: 10.1016/j.ijcard.2016.05.045

39. Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D et al. Type-II Myocardial Infarction – Patient Characteristics, Management and Outcomes. PLoS ONE. 2014;9(1):e84285. DOI: 10.1371/journal.pone.0084285

40. Rossini R, Capodanno D, Lettieri C, Musumeci G, Limbruno U, Molfese M et al. Long-Term Outcomes of Patients With Acute Coronary Syndrome and Nonobstructive Coronary Artery Disease. The American Journal of Cardiology. 2013;112(2):150–5. DOI: 10.1016/j.amjcard.2013.03.006

41. Ramanath VS, Armstrong DF, Grzybowski M, Rahnama‐Mohagdam S, Tamhane UU, Gordon K et al. Receipt of Cardiac Medications Upon Discharge Among Men and Women With Acute Coronary Syndrome and Nonobstructive Coronary Artery Disease. Clinical Cardiology. 2010;33(1):36–41. DOI: 10.1002/clc.20701

42. Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskjöld A, Gard A et al. Medical Therapy for Secondary Prevention and LongTerm Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation. 2017;135(16):1481–9. DOI: 10.1161/CIRCULATIONAHA.116.026336

43. Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T et al. Impact of aspirin on the prognosis in patients with coronary spasm without significant atherosclerotic stenosis. International Journal of Cardiology. 2016;220:328–32. DOI: 10.1016/j.ijcard.2016.06.157

44. Yu T, Tian C, Song J, He D, Sun Z, Sun Z. ACTION (acute coronary treatment and intervention outcomes network) registry-GWTG (get with the guidelines) risk score predicts long-term mortality in acute myocardial infarction. Oncotarget. 2017;8(60):102559–72. DOI: 10.18632/oncotarget.21741

45. Grodzinsky A, Arnold SV, Gosch K, Spertus JA, Foody JM, Beltrame J et al. Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease. European Heart Journal - Quality of Care and Clinical Outcomes. 2015;1(2):92–9. DOI: 10.1093/ehjqcco/qcv014

46. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019;40(3):237–69. DOI: 10.1093/eurheartj/ehy462